Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

被引：0
|
作者：
Tiago Torres
Luis Puig
Ron Vender
Charles Lynde
Stefano Piaserico
Jose M. Carrascosa
Paolo Gisondi
Esteban Daudén
Curdin Conrad
Pedro Mendes-Bastos
Paulo Ferreira
Luiz Leite
Justin D. Lu
J. Valerio
M. Bruni
F. Messina
A. Nidegger
M. Llamas-Velasco
E. del Alcazar
A. Mufti
Kyra White
G. Caldarola
Laetitia Teixeira
Paolo Romanelli
K. Desai
Spyridon Gkalpakiotis
Marco Romanelli
Jensen Yeung
Miguel Nogueira
Andrea Chiricozzi
机构：
[1] Centro Hospitalar Universitário do Porto,Department of Dermatology
[2] Instituto de Ciências Biomédicas Abel Salazar,Department of Dermatology
[3] University of Porto,Dermatology Unit, Department of Medicine
[4] Hospital de la Santa Creu i Sant Pau,Department of Dermatology
[5] McMaster University,Section of Dermatology and Venereology, Department of Medicine
[6] Lynde Institute for Dermatology,Dermatology Department
[7] University of Padua,Department of Dermatology
[8] Germans Trias i Pujol University Hospital (HUGTP),Division of Dermatology, Department of Medicine
[9] Autonomous University of Barcelona (UAB),Center for Health Technology and Services Research (CINTESIS), Institute of Biomedical Sciences Abel Salazar
[10] University of Verona,Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery
[11] Hospital Universitario de la Princesa,Department of Dermatovenereology, Third Faculty of Medicine
[12] Instituto de Investigación Sanitaria La Princesa (IIS-IP),Department of Dermatology
[13] Lausanne University Hospital CHUV,undefined
[14] University of Lausanne,undefined
[15] Hospital CUF Descobertas,undefined
[16] Clínica Médica Belém,undefined
[17] Michael G. DeGroote School of Medicine,undefined
[18] Faculty of Medicine,undefined
[19] University of Toronto,undefined
[20] Probity Medical Research,undefined
[21] Fondazione Policlinico Universitario A. Gemelli IRCCS,undefined
[22] Università Cattolica del Sacro Cuore,undefined
[23] University of Porto (ICBAS.UP),undefined
[24] University of Miami,undefined
[25] Miller School of Medicine,undefined
[26] Charles University and Kralovske Vinohrady University Hospital,undefined
[27] University of Pisa,undefined
来源：
American Journal of Clinical Dermatology | 2021年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：567 / 579
页数：12
相关论文
共 50 条
  • [21] COMPARISON OF THE DRUG SURVIVAL OF INTERLEUKIN (IL)-17 AND IL-23 INHIBITORS FOR THE TREATMENT OF PSORIASIS: A TWO-CENTER STUDY
    Kang, Kyong-Won
    Kang, Da-Hyun
    Kwon, Soon-Hyo
    Lew, Bark-Lynn
    Shin, Min Kyung
    Jeong, Ki-Heon
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [22] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    Ghoreschi, Kamran
    Balato, Anna
    Enerback, Charlotta
    Sabat, Robert
    LANCET, 2021, 397 (10275): : 754 - 766
  • [23] IL-23 and IL-17 in tuberculosis
    Khader, Shabaana A.
    Cooper, Andrea M.
    CYTOKINE, 2008, 41 (02) : 79 - 83
  • [24] Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells
    Hoeve, MA
    Savage, NDL
    de Boer, T
    Langenberg, DML
    Malefyt, RD
    Ottenhoff, THM
    Verreck, FAW
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (03) : 661 - 670
  • [25] IL-23/IL-17 axis in rheumatoid synovium: IL-23 is a determinant of svnovial IL-17 production
    Stamp, Lisa K.
    Easson, Andrea
    Higton, John
    Hessian, Paul A.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S187 - S188
  • [26] THE ROLE OF IL-23/IL-17 AND IL-12/IFN-γ PATHWAYS IN THE OUTCOME OF SEPSIS
    Cauvi, D. M.
    Williams, M. R.
    Bermudez, J. A.
    De Maio, A.
    SHOCK, 2013, 39 : 107 - 107
  • [27] Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis
    Alunno, Alessia
    Carubbi, Francesco
    Cafaro, Giacomo
    Pucci, Giacomo
    Battista, Francesca
    Bartoloni, Elena
    Giacomelli, Roberto
    Schillaci, Giuseppe
    Gerli, Roberto
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1727 - 1737
  • [28] Are IL-17 inhibitors superior to IL-23 inhibitors in reducing systemic inflammation in moderate-to-severe plaque psoriasis? A retrospective cohort study
    Ogut, Neslihan Demirel
    Ayanoglu, Mehmet Anil
    Koc Yildirim, Sema
    Erbagci, Ece
    Unal, Simge
    Gokyayla, Ece
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [29] Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors
    Huang, Yu-Huei
    Chang, Lun-Ching
    Chang, Ya-Ching
    Chung, Wen-Hung
    Yang, Shun-Fa
    Su, Shih-Chi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [30] Clinical and biological analysis of IL-12, IL-23, TNF-α and IL-17 specific targeting in mouse model of psoriasis
    Caillot, Frederique
    Rizova, Elena
    Benson, Jacqueline
    Musette, Philippe
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S55 - S55
12345